Shoko Ito

878 total citations
29 papers, 354 citations indexed

About

Shoko Ito is a scholar working on Molecular Biology, Hematology and Infectious Diseases. According to data from OpenAlex, Shoko Ito has authored 29 papers receiving a total of 354 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 11 papers in Hematology and 10 papers in Infectious Diseases. Recurrent topics in Shoko Ito's work include Clostridium difficile and Clostridium perfringens research (10 papers), Gut microbiota and health (10 papers) and Acute Myeloid Leukemia Research (7 papers). Shoko Ito is often cited by papers focused on Clostridium difficile and Clostridium perfringens research (10 papers), Gut microbiota and health (10 papers) and Acute Myeloid Leukemia Research (7 papers). Shoko Ito collaborates with scholars based in Japan and United Kingdom. Shoko Ito's co-authors include Tomoyoshi Shibuya, Akihito Nagahara, Dai Ishikawa, Keiichi Haga, Masahito Takahashi, Taro Osada, Kei Nomura, Kyoko Kuwahara‐Arai, Teruo Kirikae and Atsushi Arakawa and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and The American Journal of Gastroenterology.

In The Last Decade

Shoko Ito

29 papers receiving 348 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shoko Ito Japan	10	215	107	66	65	60	29	354
Shuntaro Ikegawa Japan	10	223 1.0×	157 1.5×	52 0.8×	194 3.0×	21 0.3×	40	493
Xuyang Xia China	10	175 0.8×	54 0.5×	39 0.6×	24 0.4×	41 0.7×	17	331
Amanda F. McCabe United States	14	113 0.5×	44 0.4×	31 0.5×	114 1.8×	43 0.7×	23	482
Yutaro Hino Japan	7	187 0.9×	165 1.5×	55 0.8×	117 1.8×	12 0.2×	20	352
Noa Simchoni United States	8	90 0.4×	49 0.5×	40 0.6×	30 0.5×	52 0.9×	11	417
Neha Gupta India	12	109 0.5×	38 0.4×	28 0.4×	64 1.0×	31 0.5×	55	420
Rimma Goldberg Australia	12	89 0.4×	22 0.2×	67 1.0×	57 0.9×	152 2.5×	35	488
Maren Stahl Germany	8	84 0.4×	45 0.4×	152 2.3×	39 0.6×	202 3.4×	10	373
Gabriella Lauriero Italy	7	157 0.7×	26 0.2×	21 0.3×	53 0.8×	36 0.6×	8	433
Kritika Ramani United States	13	114 0.5×	158 1.5×	109 1.7×	12 0.2×	22 0.4×	20	520

Countries citing papers authored by Shoko Ito

Since Specialization

Citations

This map shows the geographic impact of Shoko Ito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shoko Ito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shoko Ito more than expected).

Fields of papers citing papers by Shoko Ito

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shoko Ito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shoko Ito. The network helps show where Shoko Ito may publish in the future.

Co-authorship network of co-authors of Shoko Ito

This figure shows the co-authorship network connecting the top 25 collaborators of Shoko Ito. A scholar is included among the top collaborators of Shoko Ito based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shoko Ito. Shoko Ito is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Matsui, Katsuma, Masatoshi Matsumoto, Naoki Kawamura, et al.. (2023). 2524. Safety and Pharmacokinetics of PA-001, a New Potential COVID-19 Drug That Targets the S2 Subunit of SARS-CoV-2 Spike Protein, in Healthy Subjects. Open Forum Infectious Diseases. 10(Supplement_2). 1 indexed citations

Ito, Shoko, Masateru Katayama, Satoshi Inoue, et al.. (2022). A case of mechanical thrombectomy in a patient with idiopathic thrombocytopenic purpura. Nosotchu. 44(5). 546–551. 1 indexed citations

Fukuda, Yukiko, Satoru Takahashi, Michiko Nakamura, et al.. (2022). Radiation Myelopathy Caused by Palliative Radiotherapy and Intrathecal Methotrexate. SHILAP Revista de lepidopterología. 15(2). 674–681. 1 indexed citations

Fujiwara, Shin‐ichiro, Takashi Ikeda, Yumiko Toda, et al.. (2022). Effect of cumulative daunorubicin dose on cardiotoxicity after allogeneic stem cell transplantation. Leukemia Research. 121. 106951–106951. 5 indexed citations

Hatano, Kaoru, Shin‐ichiro Fujiwara, Kento Umino, et al.. (2022). Clinical interaction between dexamethasone and aprepitant in chemotherapy for lymphoma. Annals of Hematology. 101(6). 1211–1216. 3 indexed citations

Morita, Kaoru, Shin‐ichiro Fujiwara, Takashi Ikeda, et al.. (2020). Identification of endoscopic factors that predict poor responses to steroids in patients with gastrointestinal acute graft-versus-host disease. Bone Marrow Transplantation. 56(4). 963–967. 1 indexed citations

Ito, Shoko, Shin‐ichiro Fujiwara, Takashi Ikeda, et al.. (2019). Evaluation of thrombotic events in patients with immune thrombocytopenia. Annals of Hematology. 99(1). 49–55. 14 indexed citations

Ishikawa, Dai, Takashi Sasaki, Shoko Ito, et al.. (2019). P052 Combination therapy of fresh fecal microbial transplantation and triple-antibiotic therapy for ulcerative colitis. The American Journal of Gastroenterology. 114(1). S14–S14. 2 indexed citations

Ishikawa, Dai, Makoto Takahashi, Shoko Ito, et al.. (2019). P387 Efficacy of combination therapy of fresh faecal microbiota transplantation and triple-antibiotic therapy for ulcerative colitis. Journal of Crohn s and Colitis. 13(Supplement_1). S301–S301. 2 indexed citations

10.

Umino, Kento, Shin‐ichiro Fujiwara, Takashi Ikeda, et al.. (2018). Clinical outcomes of myeloid/lymphoid neoplasms with fibroblast growth factor receptor-1 (FGFR1) rearrangement. Hematology. 23(8). 470–477. 20 indexed citations

11.

Mashima, Kiyomi, Iekuni Oh, Takashi Ikeda, et al.. (2018). Role of Sequential Monitoring of WT1 Gene Expression in Patients With Acute Myeloid Leukemia for the Early Detection of Leukemia Relapse. Clinical Lymphoma Myeloma & Leukemia. 18(12). e521–e527. 12 indexed citations

12.

Ishikawa, Dai, Makoto Takahashi, Shoko Ito, et al.. (2018). P863 Eradication of dysbiotic indigenous species by multiple antibiotic pre-treatment contribute to effective faecal microbiota transplantation. Journal of Crohn s and Colitis. 12(supplement_1). S553–S553. 1 indexed citations

13.

Shibuya, Tomoyoshi, Keiichi Haga, Shoko Ito, et al.. (2018). Successful remission of ulcerative colitis flare-up during pregnancy with adsorptive granulomonocytapheresis plus tacrolimus. Intestinal Research. 16(3). 484–484. 4 indexed citations

14.

Mashima, Kiyomi, Takashi Ikeda, Yumiko Toda, et al.. (2018). Associations between the peripheral blood Wilms tumor gene 1 level and both bone marrow blast cells and the prognosis in patients with myelodysplastic syndrome. Leukemia & lymphoma. 60(3). 703–710. 5 indexed citations

15.

Ito, Shoko, Shin‐ichiro Fujiwara, Kiyomi Mashima, et al.. (2017). Development of acute myeloid leukemia in patients with untreated chronic lymphocytic leukemia. Annals of Hematology. 96(5). 719–724. 9 indexed citations

16.

Fujiwara, Shin‐ichiro, Takashi Ikeda, Yumiko Toda, et al.. (2017). Relationship between white blood cell count elevation and clinical response after G-CSF priming chemotherapy for acute myeloid leukemia. International Journal of Hematology. 106(3). 411–417. 1 indexed citations

17.

Umino, Kento, Shin‐ichiro Fujiwara, Takashi Ikeda, et al.. (2017). Prognostic value of the soluble interleukin-2 receptor level after patients with follicular lymphoma achieve a response to R-CHOP. Hematology. 22(9). 521–526. 6 indexed citations

18.

Fujiwara, Shin‐ichiro, Shoko Ito, Kiyomi Mashima, et al.. (2016). A low-dose cytarabine, aclarubicin and granulocyte colony-stimulating factor priming regimen versus a daunorubicin plus cytarabine regimen as induction therapy for older patients with acute myeloid leukemia: A propensity score analysis. Leukemia Research. 42. 82–87. 10 indexed citations

19.

Sugimoto, Miyuki, Shoko Ito, Kiyomi Mashima, et al.. (2016). Retrospective evaluation of the MEAM regimen as a conditioning regimen before autologous peripheral blood stem cell transplantation for lymphoma in two centers with different dosing schedules of melphalan. Annals of Hematology. 95(9). 1513–1519. 14 indexed citations

20.

Yamamoto, Chihiro, Shoko Ito, Kiyomi Mashima, et al.. (2016). Dose-reduced combination of mitoxantrone, etoposide, and cytarabine (miniMEC) for relapsed and refractory acute leukemia. Leukemia & lymphoma. 57(11). 2541–2547. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact